
Eikonizo Therapeutics
Developing therapies to improve the treatment of human disease, specifically neurodegenerative diseases.
Employees
Enterprise value
$160—240m
Authorizing premium user...
Developing therapies to improve the treatment of human disease, specifically neurodegenerative diseases.